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Su bcellular frac tiona tion 
Rat brain cortex was homogenised in 9 parts of 
0.32 M sucrose containing 1 mM sodium phosphate- 
Mg2+ buffer, pH 6.5. Primary fractions (crude nuclear, 
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mitochondrial, microsomal, soluble) and purified 
nuclei were prepared according to the method of 
Balazs and Cocks [7]. The purification of nerve- 
ending membranes (i.e. synaptic membranes) and 
vesicles from osmotically disrupted mitochondrial 
suspensions was carried out following the procedure 
of Lapetina et al. [B] , as summarized in table I, 
and the homogenity of the subfractions was checked 
by electron microscopy. The purity of the nuclear 
fraction was checked by light microscopy and DNA 
determinations [9]. All fractions to be assayed 
were resuspended in, or adjusted to, 10 mM sodium 
phosphateMg*+ buffer, pH 6.5, and kept on ice 
(maximum 3 hr) prior to incubation. 
2.2. Assay of colchicine-binding activity 
Bound 3H-colchicine was assayed by the filter- 
disc (DE81) method of Weisenberg et al. [lo], as 
modified by Wilson [ II], except that incubations 
were carried out in 10 mM sodium phosphate-Mg*’ 
buffer pH 6.5, instead of in phosphate-glutamate 
buffer [ 1 l] . The different subcellular fractions 
were diluted prior to assay to give a protein con- 
centration of 1 OO- 1000 ng/ml reaction mixture, 
in which range colchicine-binding was found, in 
preliminary experiments, to be proportional to 
protein concentration. Protein-bound 3H-colchicine 
absorbed on DE81 filter discs was counted direct- 
ly in 5 ml Bray’s solution [ 121 in a Packard 3375 
spectrometer, at 48% efficiency. Radioactivity 
measurements were carried out on triplicate sam- 
ples, and results given are based on the means of 
at least three separate xperiments (maximum 
variability between experiments f 10%). 
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Figs. l-3. Diagram showing the colchicine-binding activity in relative specific activity (RSA) in relation to percentage of protein 
for the primary fractions, the nuclear Subfractions after sucrose density centrifugation and the mitochondrial subfractions after 
osmotic shock. The relative specific activity is defines in Methods. The content of the mitochondrial subfractions is given in 
table 1. 
3H-Colchicine (specific radioactivity 1.7 Ci/mmole) 
was obtained from the Radiochemical Centre, 
Amersham. Protein concentration was determined 
by the method of Lowry et al. [ 131. 
2.3. Expression of results 
Colchicine-binding activities are expressed as 
Relative Specific Activities (RSA’s), in order to 
facilitate comparison of colchicine-binding acti- 
vity in the various subfractions with that of the 
parent fraction, whose RSA is taken to be 1. 
RSA = 
cpm % recovered in fraction 
protein recovered in fraction 
The recoveries for proteins and colchicine- 
binding activity were not less than 90% and 75%, 
in that order, throughout the subcellular fractio- 
nation procedures. 
3. Results 
3.1. Distribution of colchicine-binding (CB) activity 
in primary fractions 
After differential centrifugation of rat brain homo- 
genates prepared in buffered sucrose (see section 2.1), 
46 + 5.4% (n = 8) of the CB-activity was found in the 
soluble fraction, while the crude nuclear, mitochon- 
drial and microsomal fractions accounted for 
31 + 2.6(5), 15 + 2.7(5)and 8 * 1.7(5) percent, 
in that order, of the activity recovered. Taking the 
protein distribution into account, it is apparent from 
the data shown in fig. 1 that there was a nearly two- 
fold enrichment of CB-activity in the soluble frac- 
tion (RSA 1.88 + 0.28(8), while the RSA values for 
the particulate fractions did not exceed 1 .O. 
The crude nuclear fraction was further purified 
by centrifugation through 1.67 M sucrose [7] , yield- 
ing 3 subfractions: a purified nuclear pellet (PN), 
an intermediate soluble phase (Sol) and a floating 
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Subfractions 
Table 1 
Colchicine-binding activity of brain mitochondrial subfractions. 
----__ 
Conditions Description Colchicine- 
binding 
activity (%) 
(A) Subfractions of crude mitochondria (Mit) after osmotic shock 
Ml 20,000 g X 30 min pellet myelin, mitochondria, 
synaptic membranes 
Mz +Ms 20,OOOg X 30 min sup’t synaptic vesicles, 
membranes, soluble 
MZ 100,OOOg X 60 min pellet synaptic vesicles, 
some membranes 
80 
20 
5 
M3 100,000 g X 60 min sup? soluble 15 
(B) Subfractions of Mt after sucrose gradient centrifugation, 50,000 g for 120 min 
MI 0.8 see figs. 3 and 4 myelin 
MI 0.9 synaptic membranes, 
some myelin 
M, 1.0 synaptic membranes 
M, 1.2 synaptic membranes 
Ml (f’) mitochondria, some 
membranes 
12 
18 
21 
27 
22 
(C) Subfractions of Mz after sucrose gradient centrifigation, 50,000 g for 60 min 
&A 0.32-0.5 M sucrose synaptic vesicles 78 
membranes, some 
MzB 0.5 M sucrose synaptic vesicles 22 
Crude mitochondrial preparations were derived from rat brain cortex, and subfractionated after osmotic shock according to the 
method of Lapetina et al. [ 81. Colchicine-binding activity was assayed as specified in section 2.2 and values for individual sub- 
fractions, representing the means of at least 3 experiments, are given as a percentage of the activity recovered from the parent 
fraction. 
debris layer which were found to contain 2,80 
and 18 percent, in that order, of the activity re- 
covered from the parent fraction. The data shown 
in fig. 2 clearly demonstrate that brain nuclei ob- 
tained by this procedure represent a minor source 
of CB-activity. These findings were confirmed using 
crude nuclear preparations derived from new-born 
rat brain which, however, contained on 2% of the 
homogenate CB-activity, as compared with values 
of about 30% found for adult brain - (see above). 
The higher activity seen with adult brain can be 
more readily understood if one considers that myelin, 
which represents a minor constituent in immature 
brain, is largely responsible for the trapping of both 
soluble and particulate contaminants found in the 
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crude nuclear fraction [7] . Similarly, it is possible 
that the relatively high concentration of CBactivity 
found in the crude microsomal fraction (fig. 1) is 
due, in part at least, to the presence of small nerve- 
endings known to contaminate this fraction [ 141. 
The possibility that CB-activity in the crude 
mitochondrial fraction was due to non-mitochon- 
drial constituents (e.g., nerve-ending particles) was 
therefore investigated. 
3.2. Mitochondrial subfractions (table 1) 
It was found that the bulk of the activity present 
in crude mitochondrial suspensions disrupted by 
osmotic shock was recovered in the pellet obtained 
after low-speed centrifugation (table 1 A, subfraction 
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Fig. 4. Photograph of the gradient of Ml, made according 
to the technique of Lapetina et al. [S] , showing the sucrose 
concentrations and the various layers and pellet which were 
separated. The content of the various subfractions and their 
colchicine-binding activities are given in table 1 and fig. 3. 
M,). Most of the remaining activity was found in 
the soluble fraction (M3) obtained after further 
centrifugation at high speed, which represents 
mainly the soluble constituents of nerve-ending 
particles. Fig. 3 shows that subfraction Mr was 
a richer source of CB-activity than either MZ or 
M3. 
Further fractionation of MI by sucrose gradient 
centrifugation (fig. 4) resulted in a considerable 
enrichment of CB-activity in those fractions 
which contain predominantly synaptic membranes 
(Mr 0.9, MI 1.0 and MI 1.2, fig. 5), though this 
was not apparent if the distribution of proteins 
was not taken into account (table 1 B), Taken 
together, the fractions rich in synaptic membranes 
account for about 70% of the CB-activity of M, , 
or over half of the activity originally present in 
the crude mitochondrial fraction. This represents 
a considerable degree of localization of CB-protein 
in synaptic membranes. Similar results were ob- 
tained in experiments using l-day old rat brain and 
with highly purified synaptic membrane preparation 
obtained from beef brain (unpublished observations 
of Lagnado and Lyons). 
Finally, it was shown that most of the CB-activity 
present in Mz was associated with the synaptic ve- 
sicle fraction (M, A) purified by an additional 
sucrose gradient centrifugation step (table 1 C, fig. 6). 
4. Discussion 
An obvious question arising from the results de- 
scribed concerns the relationship of the colchicine- 
binding sites associated with nerve membrane com- 
ponents (especially synaptic membranes) with col- 
chicine-binding proteins of presumed microtubular 
origin which are present in the soluble fraction. The 
possibility that membrane components which bind 
colchicine represent stabilized forms of micro- 
tubular protein is not inconsistent with the obser- 
vation that colchicine-binding activity of synaptic 
membranes is largely retained after repeated 
washings with phosphate-buffered sucrose solutions 
containing 0.1% Triton Xl 00, or after storage of 
the membranes at - 10” for up to two weeks (Lyons 
and Lagnado, paper in preparation; cf. also [3,4]). 
This is in contrast with the rapid decay of colchicine- 
binding activity observed with soluble preparations 
under similar conditions [IO] . 
The possible significance of membrane-bound 
CB-protein in relation to microtubule structure 
and function remains a matter for speculation, espe- 
cially since to our knowledge, most of the evidence 
that the soluble colchicine-binding protein purified 
from nerve tissue represents microtubule subunit 
protein is of indirect nature [2,6]. However, it is 
perhaps worth noting that extensively purified 
colchicine-binding protein prepared from soluble 
extracts of pig brain possesses both an intrinsic 
cyclic AMP-activated phosphokinase activity [see 
also 151, as well as the capacity to bind cyclic AMP, 
as measured by the methods of Tao et al. [ 161 
(Lagnado, Lyons and Weller, paper in preparation). 
In many respects, the properties of the phosphokinase 
and cyclic AMP-binding activities present in these 
preparations were found to be similar to those ori- 
ginally described for purified synaptic membranes 
from beef brain [ 171 . 
In conclusion, it is suggested that the interruption 
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Figs. 5 and 6. Diagram showing the colchicine-binding activity in relative specific activity (RSA) in relation to the percentage of 
protein for the subfractions of Mr and the subfractions of Ma after sucrose density centrifugation. The relative specific activity 
is defined in Methods. The content of the Mt- and Mz-subfractions is given in table 1. The density gradient obtained from frac- 
tion M 1 is shown in fig. 4. 
of various physiological processes in nerve tissue 
by colchicine and related alkaloids [ 1, 21 may be 
partly due to the binding of these drugs by nerve- 
ending membranes in addition to any direct inter- 
actions they may have with microtubular proteins. 
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